BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32398023)

  • 1. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype.
    Clarke SLN; Robertson L; Rice GI; Seabra L; Hilliard TN; Crow YJ; Ramanan AV
    Pediatr Rheumatol Online J; 2020 May; 18(1):37. PubMed ID: 32398023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey.
    Balci S; Ekinci RMK; de Jesus AA; Goldbach-Mansky R; Yilmaz M
    Clin Immunol; 2020 Mar; 212():108273. PubMed ID: 31626957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome.
    Volpi S; Insalaco A; Caorsi R; Santori E; Messia V; Sacco O; Terheggen-Lagro S; Cardinale F; Scarselli A; Pastorino C; Moneta G; Cangemi G; Passarelli C; Ricci M; Girosi D; Derchi M; Bocca P; Diociaiuti A; El Hachem M; Cancrini C; Tomà P; Granata C; Ravelli A; Candotti F; Picco P; DeBenedetti F; Gattorno M
    J Clin Immunol; 2019 Jul; 39(5):476-485. PubMed ID: 31144250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy.
    Wu J; Zhou Q; Zhou H; Lu M
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):131. PubMed ID: 37884945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stimulator of interferon genes-associated vasculopathy with onset in infancy: first case report in China].
    Yu ZX; Zhong LQ; Song HM; Wang CY; Wang W; Li J; Ma MS
    Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):179-185. PubMed ID: 29518827
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.
    Frémond ML; Hadchouel A; Berteloot L; Melki I; Bresson V; Barnabei L; Jeremiah N; Belot A; Bondet V; Brocq O; Chan D; Dagher R; Dubus JC; Duffy D; Feuillet-Soummer S; Fusaro M; Gattorno M; Insalaco A; Jeziorski E; Kitabayashi N; Lopez-Corbeto M; Mazingue F; Morren MA; Rice GI; Rivière JG; Seabra L; Sirvente J; Soler-Palacin P; Stremler-Le Bel N; Thouvenin G; Thumerelle C; Van Aerde E; Volpi S; Willcocks S; Wouters C; Breton S; Molina T; Bader-Meunier B; Moshous D; Fischer A; Blanche S; Rieux-Laucat F; Crow YJ; Neven B
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):803-818.e11. PubMed ID: 33217613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).
    Kanazawa N; Ishii T; Takita Y; Nishikawa A; Nishikomori R
    Pediatr Rheumatol Online J; 2023 Apr; 21(1):38. PubMed ID: 37087470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulator of Interferon Genes-associated Vasculopathy with an Onset in Infancy Diagnosed after the Development of Atypical Pulmonary Lesions During Treatment as Juvenile Idiopathic Arthritis.
    Nishida T; Nakano K; Inoue Y; Narumi-Kishimoto Y; Kaname T; Akashi K; Tanaka Y
    Intern Med; 2021 Apr; 60(7):1109-1114. PubMed ID: 33162473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib.
    Tang X; Xu H; Zhou C; Peng Y; Liu H; Liu J; Li H; Yang H; Zhao S
    J Clin Immunol; 2020 Jan; 40(1):114-122. PubMed ID: 31705453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult-Onset ANCA-Associated Vasculitis in SAVI: Extension of the Phenotypic Spectrum, Case Report and Review of the Literature.
    Staels F; Betrains A; Doubel P; Willemsen M; Cleemput V; Vanderschueren S; Corveleyn A; Meyts I; Sprangers B; Crow YJ; Humblet-Baron S; Liston A; Schrijvers R
    Front Immunol; 2020; 11():575219. PubMed ID: 33133092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial lung disease in autoinflammatory disease in childhood: A systematic review of the literature.
    Nayir Buyuksahin H; Basaran O; Balık Z; Bilginer Y; Ozen S; Dogru D
    Pediatr Pulmonol; 2023 Feb; 58(2):367-373. PubMed ID: 36314652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STING-associated vasculopathy with onset in infancy: a familial case series report and literature review.
    Wang Y; Wang F; Zhang X
    Ann Transl Med; 2021 Jan; 9(2):176. PubMed ID: 33569478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioresistant cells initiate lymphocyte-dependent lung inflammation and IFNγ-dependent mortality in STING gain-of-function mice.
    Gao KM; Motwani M; Tedder T; Marshak-Rothstein A; Fitzgerald KA
    Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2202327119. PubMed ID: 35696583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis.
    Miserocchi E; Giuffrè C; Cornalba M; Pontikaki I; Cimaz R
    Clin Rheumatol; 2020 Mar; 39(3):847-851. PubMed ID: 31897953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferon-independent T cell impairment in a Tmem173 N153S/WT mouse model of STING associated vasculopathy with onset in infancy (SAVI).
    Siedel H; Roers A; Rösen-Wolff A; Luksch H
    Clin Immunol; 2020 Jul; 216():108466. PubMed ID: 32470544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Challenge of Diagnosing SAVI: Case Studies.
    Cao Y; Jiang LP
    Pediatr Allergy Immunol Pulmonol; 2019 Dec; 32(4):167-172. PubMed ID: 32140288
    [No Abstract]   [Full Text] [Related]  

  • 17. STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions.
    Latour-Álvarez I; Murcia-Clemente L; Vázquez-Pigueras I; Garramone-Ramírez JE; Clemente D; Sanz V; Torrelo A
    Pediatr Dermatol; 2024 Apr; ():. PubMed ID: 38682895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Tofacitinib for infant-onset STING-associated vasculopathy: A case report from China.
    Shen D; Fan X; Zhou Q; Xu X; Lu M
    Medicine (Baltimore); 2022 Dec; 101(48):e31832. PubMed ID: 36482559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.
    Sanchez GAM; Reinhardt A; Ramsey S; Wittkowski H; Hashkes PJ; Berkun Y; Schalm S; Murias S; Dare JA; Brown D; Stone DL; Gao L; Klausmeier T; Foell D; de Jesus AA; Chapelle DC; Kim H; Dill S; Colbert RA; Failla L; Kost B; O'Brien M; Reynolds JC; Folio LR; Calvo KR; Paul SM; Weir N; Brofferio A; Soldatos A; Biancotto A; Cowen EW; Digiovanna JJ; Gadina M; Lipton AJ; Hadigan C; Holland SM; Fontana J; Alawad AS; Brown RJ; Rother KI; Heller T; Brooks KM; Kumar P; Brooks SR; Waldman M; Singh HK; Nickeleit V; Silk M; Prakash A; Janes JM; Ozen S; Wakim PG; Brogan PA; Macias WL; Goldbach-Mansky R
    J Clin Invest; 2018 Jul; 128(7):3041-3052. PubMed ID: 29649002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Interstitial Lung Disease Caused by Mutation of the
    Li J; An S; Du Z
    Front Pediatr; 2020; 8():543. PubMed ID: 33014937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.